Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines

  • Authors:
    • Qiaomei Dai
    • Yaozhang Li
    • Meiqiao Wang
    • Yang Li
    • Ji Li
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China, Department of Rheumatology and Immunology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, P.R. China, Department of Chinese Formulae, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China
    Copyright: © Dai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3009-3016
    |
    Published online on: February 26, 2020
       https://doi.org/10.3892/etm.2020.8557
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Asarinin is one of the main active chemical components isolated from Xixin, a Chinese medicine. To investigate the role of asarinin in rheumatoid arthritis (RA), the present study investigated the effect of an asarinin‑medicated serum on human fibroblast‑like synoviocytes in vitro. An asarinin‑medicated serum was generated and analyzed by high‑performance liquid chromatography. Fibroblast‑like synoviocytes were isolated from patients with osteoarthritis and RA. The third generation of the rheumatoid synoviocytes was used in the experimental research and the third generation of osteoarthritic synoviocytes was used as control cells. Trypan blue staining was performed to detect the viability of RA synovial fibroblasts (RASFs). ELISA, reverse transcription‑quantitative (RT‑q) PCR and western blotting were also performed to detect the expression of various cytokines. Additionally, RT‑qPCR was employed to detect Toll‑like receptor (TLR) 2 and TLR4. The results revealed that medicated asarinin serum inhibited the viability of RASFs in a dose‑ and time‑dependent manner. The serum also suppressed the expression of interleukin (IL)‑17A, tumor necrosis factor‑α, interferon‑γ, IL‑6, TLR2 and TLR4. The inhibitory effect of asarinin drug serum on RASFs may be achieved by inhibition of T helper cell (Th)1/Th17 cytokines through suppression of TLR2 and TLR4.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Dai Q, Li Y, Zhang F, Yu H and Wang X: Therapeutic effect of low-dose IL-18 combined with IL-10 on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of Th2 responses. Rheumatol Int. 29:615–622. 2009.PubMed/NCBI View Article : Google Scholar

2 

Guggino G, Giardina AR, Raimondo S, Giardina G, Sireci G, Dieli F, Peralta M, Alessandro R, Triolo G and Ciccia F: Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion. Clin Exp Rheumato. l32:77–81. 2014.PubMed/NCBI

3 

Gonzalo-Gil E, Criado G, Santiago B, Dotor J, Pablos JL and Galindo M: Transforming growth factor (TGF)-β signalling is increased in rheumatoid synovium but TGF-β blockade does not modify experimental arthritis. Clin Exp Immunol. 174:245–255. 2013.PubMed/NCBI View Article : Google Scholar

4 

Thepmalee C, Panya A, Junking M, Chieochansin T and Yenchitsomanus PT: Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells. Hum Vaccin Immunother. 14:1423–1431. 2018.PubMed/NCBI View Article : Google Scholar

5 

Dai Q, Li J, Yun Y and Wang J: Toll-like receptor 4-myeloid differentiation primary response gene 88 pathway is involved in the shikonin treatment of CIA by regulating Treg/Th17 expression. Evid Based Complement Alternat Med. 2018(2428546)2018.PubMed/NCBI View Article : Google Scholar

6 

Dai Q, Li Y, Yu H and Wang X: Suppression of Th1 and Th17 responses and induction of Treg responses by IL-18-expressing plasmid gene combined with IL-4 on collagen-induced arthritis. Biomed Res Int. 2018(5164715)2018.PubMed/NCBI View Article : Google Scholar

7 

Müller-Ladner U, Ospelt C, Gay S, Distler O and Pap T: Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Res Ther. 9(223)2007.PubMed/NCBI View Article : Google Scholar

8 

Schönfeld C, Pap T, Neumann E and Müller-Ladner U: Fibroblasts as pathogenic cells in rheumatic inflammation. Z Rheumatol. 74:33–38. 2015.(In German). PubMed/NCBI View Article : Google Scholar

9 

Davis LS, Cush JJ, Schulze-Koops H and Lipsky PE: Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells. Arthritis Res. 3:54–64. 2001.PubMed/NCBI View Article : Google Scholar

10 

Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, Joosten LA and van den Berg WB: Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 50:3856–3865. 2004.PubMed/NCBI View Article : Google Scholar

11 

Hu F, Li Y, Zheng L, Shi L, Liu H, Zhang X, Zhu H, Tang S, Zhu L, Xu L, et al: Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and Th17 cell responses in rheumatoid arthritis. PLoS One. 9(e100266)2014.PubMed/NCBI View Article : Google Scholar

12 

Elshabrawy HA, Essani AE, Szekanecz Z, Fox DA and Shahrara S: TLRs, future potential therapeutic targets for RA. Autoimmun Rev. 16:103–113. 2017.PubMed/NCBI View Article : Google Scholar

13 

Jing Y, Zhang YF, Shang MY, Liu GX, Li YL, Wang X and Cai SQ: Chemical constituents from the roots and rhizomes of asarum heterotropoides var. mandshuricum and the in vitro anti-inflammatory activity. Molecules. 22(125)2017.PubMed/NCBI View Article : Google Scholar

14 

Gu J, Zhang L, Wang Z, Chen Y, Zhang G, Zhang D, Wang X, Bai X, Li X and Lili Z: The effect of asarinin on toll-like pathway in rats after cardiac allograft implantation. Transplant Proc. 47:545–548. 2015.PubMed/NCBI View Article : Google Scholar

15 

Park HJ, Lee KS, Zhao TT, Lee KE and Lee MK: Effects of asarinin on dopamine biosynthesis and 6-hydroxydopamine-induced cytotoxicity in PC12 cells. Arch Pharm Res. 40:631–639. 2017.PubMed/NCBI View Article : Google Scholar

16 

Zhang LL, Lu SF, Zhang S, Nie HG, Guan ZZ and Yang BF: Effect of asarinin on the acute heart transplantation rejection and the expression of adhesion molecule. Zhongguo Zhong Yao Za Zhi. 31:494–497. 2006.(In Chinese). PubMed/NCBI

17 

Dai Q, Wang M, Li Y and Li J: Amelioration of CIA by Asarinin is associated to a downregulation of TLR9/NF-κB and regulation of Th1/Th2/Treg expression. Biol Pharm Bull. 42:1172–1178. 2019.PubMed/NCBI View Article : Google Scholar

18 

Xiong Y, Jing Y, Shang M, Li C, Ye J, Wang X and Cai S: Anti-inflammatory and anti-nociceptive effects in mice of water and ethanol extracts of roots and rhizomes of Asarum heterotropoides var. mandshuricum. Zhongguo Zhong Yao Za Zhi. 34:2252–2257. 2009.(In Chinese). PubMed/NCBI

19 

He Q, Liu Q, Chen Y, Meng J and Zou L: Long-zhi decoction medicated serum promotes angiogenesis in human umbilical vein endothelial cells based on autophagy. Evid Based Complement Alternat Med. 2018(6857398)2018.PubMed/NCBI View Article : Google Scholar

20 

Hu X, Lu H, Deng YL, Wan Q and Yie SM: Effect of rat medicated serum containing Zuo Gui Wan and/or You Gui Wan on the differentiation of stem cells derived from human first trimester umbilical cord into oocyte-like cells in vitro. Evid Based Complement Alternat Med. 2015(825805)2015.PubMed/NCBI View Article : Google Scholar

21 

Aaltonen K, Niemelä T, Sankari S and Tulamo RM: Determination of the unsaturated disaccharides of hyaluronic acid in equine synovial fluid by high-performance liquid chromatography and fluorescence detection. Acta Vet Scand. 57(12)2015.PubMed/NCBI View Article : Google Scholar

22 

Di Y, Zhao M, Nie Y, Wang F and Lv J: A high-performance liquid chromatography: Chemiluminescence method for potential determination of vardenafil in dietary supplement. J Autom Methods Manag Chem. 2011(982186)2011.PubMed/NCBI View Article : Google Scholar

23 

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al: 2010 rheumatoid arthritis classification criteria: An American college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581. 2010.PubMed/NCBI View Article : Google Scholar

24 

Klein K, Aeschlimann A, Jordan S, Gay R, Gay S and Sprott H: ATP induced brain-derived neurotrophic factor expression and release from osteoarthritis synovial fibroblasts is mediated by purinergic receptor P2X4. PLoS One. 7(e36693)2012.PubMed/NCBI View Article : Google Scholar

25 

He Y, Zhu Q, Chen M, Huang Q, Wang W, Li Q, Huang Y and Di W: The changing 50% inhibitory concentration (IC50) of cisplatin: A pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget. 25:70803–70821. 2016.PubMed/NCBI View Article : Google Scholar

26 

Rai Y, Pathak R, Kumari N, Sah DK, Pandey S, Kalra N, Soni R, Dwarakanath BS and Bhatt AN: Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci Rep. 8(1531)2018.PubMed/NCBI View Article : Google Scholar

27 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Dleta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

28 

Neumann E, Lefèvre S, Zimmermann B, Gay S and Müller-Ladner U: Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med. 16:458–468. 2010.PubMed/NCBI View Article : Google Scholar

29 

Dai Q, Fang J and Zhang FS: Dual role of shikonin in early and late stages of collagen type Ⅱ arthritis. Mol Biol Rep. 36:1597–1604. 2009.PubMed/NCBI View Article : Google Scholar

30 

Kinoshita M, Kuranaga N, Matsumoto A, Ono S, Shinomiya N, Hiraide H and Seki S: Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection. Clin Exp Immunol. 143:41–49. 2006.PubMed/NCBI View Article : Google Scholar

31 

Weaver CT, Harrington LE, Mangan PR, Gavrieli M and Murphy KM: Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity. 24:677–688. 2006.PubMed/NCBI View Article : Google Scholar

32 

Veenbergen S, Smeets RL, Bennink MB, Arntz OJ, Joosten LA, van den Berg WB and vandeLoo FA: The natural soluble form of IL-18 receptor β exacerbates collagen-induced arthritis via modulation of T-cell immune responses. Ann Rheum Dis. 69:276–283. 2010.PubMed/NCBI View Article : Google Scholar

33 

Croft AP, Naylor AJ, Marshall JL, Hardie DL, Zimmermann B, Turner J, Desanti G, Adams H, Yemm AI, Müller-Ladner U, et al: Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther. 18(270)2016.PubMed/NCBI View Article : Google Scholar

34 

Bustamante MF, Garcia-Carbonell R, Whisenant KD and Guma M: Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 19(110)2017.PubMed/NCBI View Article : Google Scholar

35 

Lefèvre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, Korb A, Schnäker EM, Tarner IH, Robbins PD, et al: Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 15:1414–1420. 2009.PubMed/NCBI View Article : Google Scholar

36 

Alzabin S, Abraham SM, Taher TE, Palfreeman A, Hull D, McNamee K, Jawad A, Pathan E, Kinderlerer A, Taylor PC, et al: Incomplete response of inflammatory arthritis to TNF-α blockade is associated with the Th17 pathway. Ann Rheum Dis. 71:1741–1748. 2012.PubMed/NCBI View Article : Google Scholar

37 

Bevington SL, Cauchy P, Withers DR, Lane PJ and Cockerill PN: T cell receptor and cytokine signaling can function at different stages to establish and maintain transcriptional memory and enable T helper cell differentiation. Front Immunol. 8(204)2017.PubMed/NCBI View Article : Google Scholar

38 

Macallan DC, Borghans JA and Asquith B: Human T cell memory: A dynamic view. Vaccines (Basel). 4(E5)2017.PubMed/NCBI View Article : Google Scholar

39 

Yanes RE, Gustafson CE, Weyand CM and Goronzy JJ: Lymphocyte generation and population homeostasis throughout life. Semin Hemato. 54:33–38. 2017.PubMed/NCBI View Article : Google Scholar

40 

Nakae S, Nambu A, Sudo K and Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 171:6173–6177. 2003.PubMed/NCBI View Article : Google Scholar

41 

Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA and van den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance. J Immunol. 170:2655–2662. 2003.PubMed/NCBI View Article : Google Scholar

42 

Mellado M, Martínez-Muñoz L, Cascio G, Cascio G, Lucas P, Pablos JL and Rodríguez-Frade JM: T cell migration in rheumatoid arthritis. Front Immunol. 27(384)2015.PubMed/NCBI View Article : Google Scholar

43 

Millán O and Brunet M: Cytokine-based immune monitoring. Clin Biochem. 49:338–346. 2016.PubMed/NCBI View Article : Google Scholar

44 

Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, Mao H and Qiu Y: MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway. Diagn Pathol. 10(72)2015.PubMed/NCBI View Article : Google Scholar

45 

Shikhagaie MM, Germar K, Bal SM, Ros XR and Spits H: Innate lymphoid cells in autoimmunity: Emerging regulators in rheumatic diseases. Nat Rev Rheumatol. 13:164–173. 2017.PubMed/NCBI View Article : Google Scholar

46 

Ahmad SF, Zoheir KM, Abdel-Hamied HE, Ashour AE, Bakheet SA, Attia SM and Abd-Allah AR: Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines. Cell Immunol. 287:112–120. 2014.PubMed/NCBI View Article : Google Scholar

47 

Lubberts E: Th17 cytokines and arthritis. Semin Immunopathol. 32:43–53. 2010.PubMed/NCBI View Article : Google Scholar

48 

de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, Zuurmond AM, Schoones J, Toes RE, Huizinga TW and Kloppenburg M: Synovial inflammation, immune cells and their cytokines in osteoarthritis: A review. Osteoarthritis Cartilage. 20:1484–1499. 2012.PubMed/NCBI View Article : Google Scholar

49 

Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 39:1781–1790. 1996.PubMed/NCBI View Article : Google Scholar

50 

Abdollahi-Roodsaz S, Joosten LA, Helsen MM, Walgreen B, van Lent PL, van den Bersselaar LA, Koenders MI and van den Berg WB: Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum. 58:3753–3764. 2008.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Dai Q, Li Y, Wang M, Li Y and Li J: TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Exp Ther Med 19: 3009-3016, 2020.
APA
Dai, Q., Li, Y., Wang, M., Li, Y., & Li, J. (2020). TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Experimental and Therapeutic Medicine, 19, 3009-3016. https://doi.org/10.3892/etm.2020.8557
MLA
Dai, Q., Li, Y., Wang, M., Li, Y., Li, J."TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines". Experimental and Therapeutic Medicine 19.4 (2020): 3009-3016.
Chicago
Dai, Q., Li, Y., Wang, M., Li, Y., Li, J."TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines". Experimental and Therapeutic Medicine 19, no. 4 (2020): 3009-3016. https://doi.org/10.3892/etm.2020.8557
Copy and paste a formatted citation
x
Spandidos Publications style
Dai Q, Li Y, Wang M, Li Y and Li J: TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Exp Ther Med 19: 3009-3016, 2020.
APA
Dai, Q., Li, Y., Wang, M., Li, Y., & Li, J. (2020). TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines. Experimental and Therapeutic Medicine, 19, 3009-3016. https://doi.org/10.3892/etm.2020.8557
MLA
Dai, Q., Li, Y., Wang, M., Li, Y., Li, J."TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines". Experimental and Therapeutic Medicine 19.4 (2020): 3009-3016.
Chicago
Dai, Q., Li, Y., Wang, M., Li, Y., Li, J."TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of Th1/Th17 cytokines". Experimental and Therapeutic Medicine 19, no. 4 (2020): 3009-3016. https://doi.org/10.3892/etm.2020.8557
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team